Status:
COMPLETED
3 Dimensional Sonography Imaging
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
New Imaging Modality
Eligibility:
FEMALE
18-45 years
Brief Summary
The study is designed to evaluate a new imaging modality, 3-dimmensional sonographic volumetric analysis, and compare it to the conventional 2-dimmensional analysis that is currently in place. Those p...
Detailed Description
The benefits of the study is that 3-dimensional sonographic volumetric analysis may be a superior imaging modality for sonographically assessing oocyte maturity and may lead to change in clinical prac...
Eligibility Criteria
Inclusion
- All patients (oocyte donors and autologous oocyte patients)with a serum estradiol \> 2000pg/ML.
Exclusion
- All patients not meeting the estradiol criteria.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 16 2016
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT01872559
Start Date
December 1 2012
End Date
September 16 2016
Last Update
May 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College
New York, New York, United States, 10065